Determination of avidity of IgG against protein antigens from Streptococcus pneumoniae: assay development and preliminary application in clinical settings

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Journal of Clinical Microbiology and Infectious Diseases

• Publication date

  2017-10-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10096-017-3103-8PMID 29027028
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Pneumococcal Conjugate Vaccine on the Natural Antibodies and Antibody Responses Against Protein Antigens From Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Children With Community-acquired Pneumonia

  2016cited by this paper
• Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life

  2016cited by this paper
• Serological diagnosis of pneumococcal infection in children with pneumonia using protein antigens: A study of cut-offs with positive and negative controls.

  2016cited by this paper
• Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine in adults, toddlers, and infants: A phase I randomized controlled study.

  2015cited by this paper
• Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection

  2015cited by this paper
• Proteomics-driven design of a multiplex bead-based platform to assess natural IgG antibodies to pneumococcal protein antigens in children.

  2015cited by this paper
• Diagnostic Methods for and Clinical Pictures of Polyomavirus Primary Infections in Children, Finland

  2014cited by this paper
• A fluorescent multiplexed bead-based immunoassay (FMIA) for quantitation of IgG against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis protein antigens.

  2014cited by this paper
• Low opsonic activity to the infecting serotype in pediatric patients with invasive pneumococcal disease.

  2013cited by this paper
• Concentration and High Avidity of Pneumococcal Antibodies Persist at Least 4 Years after Immunization with Pneumococcal Conjugate Vaccine in Infancy

  2013cited by this paper
• Correlation of Pneumococcal Antibody Concentration and Avidity with Patient Clinical and Immunologic Characteristics

  2013cited by this paper
• PcpA of Streptococcus pneumoniae mediates adherence to nasopharyngeal and lung epithelial cells and elicits functional antibodies in humans.

  2012cited by this paper
• PspA Family Distribution, unlike Capsular Serotype, Remains Unaltered following Introduction of the Heptavalent Pneumococcal Conjugate Vaccine

  2012cited by this paper
• Association of Human Bocavirus 1 Infection with Respiratory Disease in Childhood Follow-up Study, Finland

  2012cited by this paper
• Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults.

  2012cited by this paper
• Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans.

  2012cited by this paper
• Universal protein vaccines against Neisseria meningitidis serogroup B, Streptococcus pneumoniae and influenza

  2011cited by this paper
• Antibody and T-cell responses during acute and convalescent stages of invasive pneumococcal disease.

  2011cited by this paper
• Novel Protein-Based Pneumococcal Vaccines Administered with the Th1-Promoting Adjuvant IC31 Induce Protective Immunity against Pneumococcal Disease in Neonatal Mice

  2011cited by this paper
• Absence of pneumococcal PcsB is associated with overexpression of LysM domain-containing proteins.

  2011cited by this paper
• Immunity to pneumococcal surface proteins in children with community-acquired pneumonia: a distinct pattern of responses to pneumococcal choline-binding protein A.

  2011cited by this paper
• The pneumococcal eukaryotic-type serine/threonine protein kinase StkP co-localizes with the cell division apparatus and interacts with FtsZ in vitro.

  2010cited by this paper
• Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.

  2009cited by this paper
• Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models.

  2009cited by this paper
• Pathogenesis, treatment, and prevention of pneumococcal pneumonia.

  2009cited by this paper
• Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies

  2008cited by this paper
• Social Mixing with Other Children during Infancy Enhances Antibody Response to a Pneumococcal Conjugate Vaccine in Early Childhood

  2007cited by this paper
• Functional Antibodies Elicited by Two Heptavalent Pneumococcal Conjugate Vaccines in the Finnish Otitis Media Vaccine Trial

  2007cited by this paper
• Streptococcus pneumoniae Protein Vaccine Candidates: Properties, Activities and Animal Studies

  2006cited by this paper
• Identification and Characterization of a Novel Family of Pneumococcal Proteins That Are Protective against Sepsis

  2001cited by this paper
• Antibody response to the pneumococcal proteins pneumococcal surface adhesin A and pneumolysin in children with acute otitis media

  2001cited by this paper
• Protection against Streptococcus pneumoniae Elicited by Immunization with Pneumolysin and CbpA

  2001cited by this paper
• The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection.

  2000cited by this paper
• Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for Pneumococcal pneumonia.

  2000cited by this paper
• Contribution of serotype‐specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae

  1999cited by this paper
• Avidity as a Determinant of the Protective Efficacy of Human Antibodies to Pneumococcal Capsular Polysaccharides

  1999cited by this paper
• The pspC Gene of Streptococcus pneumoniae Encodes a Polymorphic Protein, PspC, Which Elicits Cross-Reactive Antibodies to PspA and Provides Immunity to Pneumococcal Bacteremia

  1999cited by this paper
• Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.

  1992cited by this paper
• Antibody avidity determination by ELISA using thiocyanate elution.

  1986cited by this paper

• Novel processes to obtain pneumococcal surface proteins for vaccines

  2025cites this paper
• Navigating diagnostic options for inborn errors of immunity in children: a case-based illustration

  2022cites this paper
• Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life

  2016cites this paper